CliffBio
small molecule

CLONIDINE HYDROCHLORIDE

CLONIDINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLONIDINE HYDROCHLORIDE
Active ingredientCLONIDINE HYDROCHLORIDE
Strength5MG/10ML (0.5MG/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJuly 2011
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.